N-((1S)-1-{[4-((2S)-2-{[2,4-Dichlorophenyl)sulfonyl]amino} -3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl-1-benzothiophene-2- carboxamide (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: Part I (Journal of Pharmacology and Experimental Therapeutics (2008) 326, (432-442))

K. S. Thorneloe, A. C. Sulpizio, Z. Lin, D. J. Figueroa, A. K. Clouse, G. P. McCafferty, T. P. Chendrimada, E. S. Lashinger, E. Gordon, L. Evans, B. A. Misajet, D. J. DeMarini, J. H. Nation, L. N. Casillas, R. W. Marquis, B. J. Votta, S. A. Sheardown, X. Xu, D. P. Brooks, N. J. LapingT. D. Westfall

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)410
Number of pages1
JournalJournal of Pharmacology and Experimental Therapeutics
Volume338
Issue number1
StatePublished - Jul 2011

Cite this